Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study Evaluating the Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia and Improvement of Quality of Life for Individuals with Spinal Cord Injury

Trial Profile

A Study Evaluating the Effect of Botox Treatment for Neurogenic Detrusor Overactivity on the Prevention of Autonomic Dysreflexia and Improvement of Quality of Life for Individuals with Spinal Cord Injury

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2018

At a glance

  • Drugs Botulinum-Toxin-A (Primary)
  • Indications Neurogenic bladder
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 22 May 2018 New trial record
    • 21 May 2018 Results presented at the 113th Annual Meeting of the American Urological Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top